Ann Winter-Vann, PhD

Ann Winter-Vann, PhD

Director of Medical Writing Services

Ann Winter-Vann joined Whitsell Innovations (WI) in 2007. As the Director of Medical Writing Services, she provides strategic leadership for the medical writing, quality control, and publishing services within WI. Dr. Winter-Vann has extensive experience writing clinical research and regulatory documents for the US Food and Drug Administration, the European Medicines Agency, and for submission to other regulatory agencies.

Dr. Winter-Vann’s area of expertise is oncology, but she also has experience in the therapeutic areas of virology, gastroenterology, ophthalmology, central nervous system, pain, respiratory, cardiology, immunology, allergy, and dermatology. In addition to clinical regulatory documents, Dr. Winter-Vann has written publications, educational modules, sales aids, and patient education materials. She also leads in-house training sessions on regulatory and medical writing.

Dr. Winter-Vann is a past president of the American Medical Writers Association (AMWA). She is currently on the Board of Directors of AMWA and is currently serving as Chair of the Education Committee. Dr. Winter-Vann is a Fellow of AMWA, and in 2020, she was awarded an Excellence in Service Award from the Drug Information Association (DIA).

Dr. Winter-Vann received her PhD in molecular cancer biology from Duke University, where she was supported by a fellowship from the Howard Hughes Medical Institute. In her graduate research, Dr. Winter-Vann studied the role of methotrexate on post-translational processing and cell signaling in oncogenesis. As an extension of that research, she helped identify a novel small molecule inhibitor of isoprenylcysteine carboxyl methyltransferase, which is currently being investigated as a chemotherapeutic agent. Prior to joining WI, Dr. Winter-Vann was a postdoctoral researcher in the Department of Pharmacology at the University of North Carolina at Chapel Hill, where her research focused on cell signaling and metastasis.